HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

Other languages Hansoh Pharmaceutical Group Company Limited

Equities

3692

KYG549581067

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 EDT			5-day change	1st Jan Change
17.22 ^HKD	+2.50%		+11.96%	+9.26%

04-03	Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug	MT
04-03	Hansoh Pharmaceutical Group Company Limited, Jiangsu Hansoh Pharmaceutical Group Company Limited and Shanghai Hansoh Biomedical Technology Company Limited Receives Grant of A Clinical Trial Notice Issued by the National Medical Products Administration of the People's Republic of China to Be Used for the Treatment of Advanced Non-Small Cell Lung Cancer	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug	04-03
Hansoh Pharmaceutical Group Company Limited, Jiangsu Hansoh Pharmaceutical Group Company Limited and Shanghai Hansoh Biomedical Technology Company Limited Receives Grant of A Clinical Trial Notice Issued by the National Medical Products Administration of the People's Republic of China to Be Used for the Treatment of Advanced Non-Small Cell Lung Cancer	04-03
Hansoh Pharmaceutical Group Company Limited Recommends Final Dividend, Payable on July 17, 2024	03-26
Hansoh Pharmaceutical Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-26
Hansoh Pharmaceutical Gets Nod to Trial Nephropathy Treatment Capsules	02-08
Hansoh Pharmaceutical Buys Back 3 Million Shares	01-31
Fed, China Property Outlooks Roil Asian Stock Markets	01-30
Hansoh Secures Chinese Nod For Clinical Trial Of Anti-Diabetes Drug	01-23
China Outlook, Tech Rally Roils Asian Stock Markets	01-19
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of HS-10509 Tablets	01-17
Federal Reserve Outlook Mutes Asian Stock Markets	01-05
GSK plc Enters Exclusive License Agreement with Hansoh for HS-20093	12-20
Games Workshop seals Amazon deal for Warhammer 40,000	12-18
GSK looks for deals in China as rebuilds relationship	12-17
Shanghai Hansoh Biomedical Technology Company Limited and Jiangsu Hansoh Pharmaceutical Group Company Limited Receives Clinical Trial Notice	11-10
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of Hs-20106 Injections	23-10-19
Las acciones de Hong Kong suben un 0,8%; las esperanzas de estímulo de China animan el ánimo -- Market Talk	23-09-27
Rising Interest Rates Blunt Asian Stock Markets	23-09-26
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of "HS-20105"	23-09-25
Hansoh Pharmaceutical Group’s Attributable Profit Slides in H1	23-09-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Hansoh Pharmaceutical Group Company Limited

Equities

3692

KYG549581067

Other languages

Filters